next PH Co., Ltd.

next PH Co., Ltd. is a Japanese company that operates dispensing pharmacies (chōzai yakkyoku). It was established in October 2024 as a wholly owned subsidiary of Pharmarise Holdings Corporation, a Tokyo Stock Exchange Standard Market-listed pharmacy group. The company was created specifically to receive the dispensing pharmacy business of the Kanichi Shoten group, which had filed for civil rehabilitation proceedings in 2024. Its headquarters are in Nakano, Tokyo, the same location as its parent company. The company operates pharmacies across a wide area of Japan. According to its official corporate profile, it runs 54 dispensing pharmacies across one dō (Hokkaido), one fu (Kyoto), and eight prefectures: Hokkaido, Aomori, Niigata, Nagano, Saitama, Aichi, Gifu, Shiga, Kyoto, and Miyazaki. The pharmacies it acquired from the Kanichi Shoten group were rebranded under the Pharmarise Pharmacy or Trim Pharmacy names. The company's business purpose is the operation of dispensing pharmacies, and it positions itself as a community-based health hub, aiming to be a trusted family pharmacy and pharmacist in line with the government's community-based integrated care system. next PH is part of the Pharmarise Group, whose corporate philosophy is encapsulated in the word "Perfect." The group's core business is dispensing pharmacies, and it also operates drugstores and other health-related businesses. The company's representative director is Keiko Matsuura. As of May 31, 2025, it had 295 employees and 54 pharmacies. Its fiscal year ends on March 31. The company's capital is 10 million yen. The establishment of next PH reflects the ongoing consolidation in Japan's pharmacy industry, driven by competition, M&A, and government healthcare cost containment policies. Pharmarise Holdings, which was founded in 1984 and has been listed on the Tokyo Stock Exchange since 2007, has been an active acquirer in this environment. The creation of next PH as a dedicated subsidiary to absorb the Kanichi Shoten pharmacy business is part of Pharmarise's growth strategy and its efforts to contribute to local healthcare.

next PH Co., Ltd. was established on October 10, 2024, as a wholly owned subsidiary of Pharmarise Holdings Corporation. Its creation was directly linked to the bankruptcy of Kanichi Shoten Co., Ltd., a Kyoto-based company that operated dispensing pharmacies under names such as "Nagisa Pharmacy." Kanichi Shoten had been struggling due to intensifying competition from large drugstore chains and pharmacy chains, as well as difficulties in repaying loans taken out for M&A activities. In 2024, the situation worsened when it could no longer secure financing from investor companies, leading to a further deterioration in cash flow. On July 26, 2024, Kanichi Shoten and eight other group companies filed for civil rehabilitation proceedings with the Tokyo District Court, and on August 31, 2024, the court issued a decision to commence civil rehabilitation proceedings. Pharmarise Holdings was selected as the rehabilitation sponsor. On September 24, 2024, Kanichi Shoten and Pharmarise Holdings signed an agreement to transfer the dispensing pharmacy business operated by the Kanichi Shoten group to Pharmarise Holdings effective December 1, 2024. Initially, the rehabilitation scheme planned for group companies such as Pharmarise and Hokkaido Pharmarise to take over the business. However, the method was changed to have next PH Co., Ltd., established on October 10, 2024, absorb the business through an absorption-type company split effective December 2, 2024. next PH's headquarters was placed in Nakano, Tokyo, the same location as Pharmarise Holdings, and its president was to be concurrently held by the president of Pharmarise. On December 1, 2024, Pharmarise Holdings took over the dispensing pharmacy business from the Kanichi Shoten group, and on the following day, December 2, 2024, the business was succeeded by next PH through an absorption-type company split. The pharmacies acquired by next PH from the Kanichi Shoten group were renamed to Pharmarise Pharmacy or Trim Pharmacy, which are operated by the group company Pharmarise. As of May 31, 2025, next PH operated 54 dispensing pharmacies across Hokkaido, Aomori, Niigata, Nagano, Saitama, Aichi, Gifu, Shiga, Kyoto, and Miyazaki prefectures. The company had 295 employees and capital of 10 million yen. Its fiscal year ends on March 31. The representative director is Keiko Matsuura. The company is part of the Pharmarise Group, which was founded in 1984 and has been listed on the Tokyo Stock Exchange since 2007, currently on the Standard Market. The group's corporate philosophy is "Perfect," and it aims to contribute to community healthcare.

• Kanichi Shoten and eight group companies file for civil rehabilitation proceedings with the Tokyo District Court.

• Tokyo District Court issues decision to commence civil rehabilitation proceedings for Kanichi Shoten group.

• Kanichi Shoten and Pharmarise Holdings sign agreement to transfer the dispensing pharmacy business to Pharmarise Holdings effective December 1, 2024.

• next PH Co., Ltd. is established.

• Pharmarise Holdings takes over the dispensing pharmacy business from the Kanichi Shoten group.

• next PH succeeds the dispensing pharmacy business and 54 stores through an absorption-type company split.

A community-based pharmacy operator within the Pharmarise Group, aiming to be a trusted family pharmacy and health hub under the "Perfect" philosophy.

• Dispensing pharmacy services

  Operation of dispensing pharmacies providing prescription dispensing and medication guidance.

1. 1関連会社：ｎｅｘｔ ＰＨ株式会社｜調剤薬局のファーマライズホールディングス株式会社pharmarise.com
2. 2代表メッセージ｜調剤薬局のファーマライズホールディングス株式会社pharmarise.com
3. 3関連会社一覧｜調剤薬局のファーマライズホールディングス株式会社pharmarise.com
4. 4店舗検索｜調剤薬局のファーマライズホールディングス株式会社pharmarise.com
5. 5next Ph - Wikidatawikidata.org
6. 6Next PH - Wikipediaja.wikipedia.org